Compound used as dual inhibitor for RAAS (rennin angiotensin aldosterone system)
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZHEJIANG YONGTAI TECH CO LTD
- Publication Date
- 2015-04-08
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a compound as a dual inhibitor of renin-angiotensin-aldosterone (RAAS) system, which can be used for treating diseases related to the RAS system, including hypertension, heart disease and the like. Background technique
[0002] The renin-angiotensin-aldosterone system (RAAS) is a complex and highly efficient system necessary for the regulation of blood flow, electrolyte balance, and arterial blood pressure. The two main parts of this system are renin and angiotensin transferase. Renin is an aspartyl protease that converts angiotensinogen produced in the liver into angiotensin I, and angiotensin I generates blood vessels under the action of angiotensin I converting enzyme (ACE) Tensin II is finally converted into angiotensin III that can promote aldosterone secretion and inactivated. Angiotensin Ⅱ is a powerful peptide vasoconstrictor that can promote the release of norepinephrine from nerve endings, and can also activate prot...